Wolf, Rasmus Trap
Jeppesen, Pia
Pedersen, Mette Maria Agner
Puggaard, Louise Berg
Thastum, Mikael
Bilenberg, Niels
Thomsen, Per Hove
Silverman, Wendy K.
Plessen, Kerstin Jessica
Neumer, Simon-Peter
Correll, Christoph U.
Pagsberg, Anne Katrine
Gyrd-Hansen, Dorte
Funding for this research was provided by:
TrygFonden
Lundbeckfonden
Article History
Received: 11 November 2021
Accepted: 8 June 2022
First Online: 24 June 2022
Declarations
:
: All the experiment protocol involving humans was in accordance with the Declaration of Helsinki. Ethical approval of the Mind My Mind study was provided by the Regional Committee on Health Research Ethics in the Capital Region of Denmark, Journal-nr.: H-17011408. Participation was voluntary, and data was kept confidential. The parents gave written consent to the study participation.
: Not applicable.
: RTW, LBP, MMAP, AKP, WKS, KJP, SPN, DGH, MT, NB, PHT and PJ declare that they have no conflict of interest. CUC has been a consultant and/or advisor to or has received honoraria from: Acadia, Alkermes, Allergan, Angelini, Axsome, Gedeon Richter, Gerson Lehrman Group, IntraCellular Therapies, Janssen/J&J, LB Pharma, Lundbeck, MedAvante-ProPhase, Medscape, Neurocrine, Noven, Otsuka, Pfizer, Recordati, Rovi, Sumitomo Dainippon, Sunovion, Supernus, Takeda, and Teva. He has provided expert testimony for Janssen and Otsuka. He served on a Data Safety Monitoring Board for Lundbeck, Rovi, Supernus, and Teva. He received royalties from UpToDate and grant support from Janssen and Takeda. He is also a stock option holder of LB Pharma.